Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'caspase 14'
(id=5917513 ; fe=caspase 14 ; type=777 ; niveau=200 ; luminosité=25 ; somme entrante=1137 creation date=2017-05-30 touchdate=2025-06-08 09:49:55.000)
≈ 36 relations sortantes

  1. caspase 14 -- r_associated #0: 74 / 1 -> chimie
    n1=caspase 14 | n2=chimie | rel=r_associated | relid=0 | w=74
  2. caspase 14 -- r_associated #0: 59 / 0.797 -> en:analysis aspect
    n1=caspase 14 | n2=en:analysis aspect | rel=r_associated | relid=0 | w=59
  3. caspase 14 -- r_associated #0: 59 / 0.797 -> en:caspase-7
    n1=caspase 14 | n2=en:caspase-7 | rel=r_associated | relid=0 | w=59
  4. caspase 14 -- r_associated #0: 59 / 0.797 -> en:exposure as collected domain
    n1=caspase 14 | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=59
  5. caspase 14 -- r_associated #0: 59 / 0.797 -> en:historical aspects qualifier
    n1=caspase 14 | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=59
  6. caspase 14 -- r_associated #0: 59 / 0.797 -> en:standards characteristics
    n1=caspase 14 | n2=en:standards characteristics | rel=r_associated | relid=0 | w=59
  7. caspase 14 -- r_associated #0: 58 / 0.784 -> en:bioformation
    n1=caspase 14 | n2=en:bioformation | rel=r_associated | relid=0 | w=58
  8. caspase 14 -- r_associated #0: 58 / 0.784 -> en:caspase-6
    n1=caspase 14 | n2=en:caspase-6 | rel=r_associated | relid=0 | w=58
  9. caspase 14 -- r_associated #0: 58 / 0.784 -> en:genetic aspects
    n1=caspase 14 | n2=en:genetic aspects | rel=r_associated | relid=0 | w=58
  10. caspase 14 -- r_associated #0: 58 / 0.784 -> en:ultrastructure
    n1=caspase 14 | n2=en:ultrastructure | rel=r_associated | relid=0 | w=58
  11. caspase 14 -- r_associated #0: 57 / 0.77 -> en:metabolic aspects
    n1=caspase 14 | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=57
  12. caspase 14 -- r_associated #0: 57 / 0.77 -> en:physiological aspects
    n1=caspase 14 | n2=en:physiological aspects | rel=r_associated | relid=0 | w=57
  13. caspase 14 -- r_associated #0: 57 / 0.77 -> en:therapeutic use - qualifier
    n1=caspase 14 | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=57
  14. caspase 14 -- r_associated #0: 56 / 0.757 -> en:aspects of radiation effects
    n1=caspase 14 | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=56
  15. caspase 14 -- r_associated #0: 56 / 0.757 -> en:caspases, effector
    n1=caspase 14 | n2=en:caspases, effector | rel=r_associated | relid=0 | w=56
  16. caspase 14 -- r_associated #0: 56 / 0.757 -> en:deficiency aspects
    n1=caspase 14 | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=56
  17. caspase 14 -- r_associated #0: 56 / 0.757 -> en:in urine
    n1=caspase 14 | n2=en:in urine | rel=r_associated | relid=0 | w=56
  18. caspase 14 -- r_associated #0: 54 / 0.73 -> en:caspase-3
    n1=caspase 14 | n2=en:caspase-3 | rel=r_associated | relid=0 | w=54
  19. caspase 14 -- r_associated #0: 54 / 0.73 -> en:drug effect
    n1=caspase 14 | n2=en:drug effect | rel=r_associated | relid=0 | w=54
  20. caspase 14 -- r_associated #0: 54 / 0.73 -> en:taxonomic
    n1=caspase 14 | n2=en:taxonomic | rel=r_associated | relid=0 | w=54
  21. caspase 14 -- r_associated #0: 53 / 0.716 -> en:chemical aspects
    n1=caspase 14 | n2=en:chemical aspects | rel=r_associated | relid=0 | w=53
  22. caspase 14 -- r_associated #0: 53 / 0.716 -> en:chemical synthesis
    n1=caspase 14 | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=53
  23. caspase 14 -- r_associated #0: 53 / 0.716 -> en:in blood
    n1=caspase 14 | n2=en:in blood | rel=r_associated | relid=0 | w=53
  24. caspase 14 -- r_associated #0: 53 / 0.716 -> en:poisoning aspects
    n1=caspase 14 | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=53
  25. caspase 14 -- r_associated #0: 52 / 0.703 -> en:in cerebrospinal fluid
    n1=caspase 14 | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=52
  26. caspase 14 -- r_associated #0: 51 / 0.689 -> en:aspects of adverse effects
    n1=caspase 14 | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=51
  27. caspase 14 -- r_associated #0: 51 / 0.689 -> en:immunology aspects
    n1=caspase 14 | n2=en:immunology aspects | rel=r_associated | relid=0 | w=51
  28. caspase 14 -- r_associated #0: 51 / 0.689 -> en:mechanism of action qualifier
    n1=caspase 14 | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=51
  29. caspase 14 -- r_associated #0: 51 / 0.689 -> en:pharmacokinetic aspects
    n1=caspase 14 | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=51
  30. caspase 14 -- r_associated #0: 51 / 0.689 -> en:toxicity aspects
    n1=caspase 14 | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=51
  31. caspase 14 -- r_associated #0: 30 / 0.405 -> en:cellular secretion
    n1=caspase 14 | n2=en:cellular secretion | rel=r_associated | relid=0 | w=30
  32. caspase 14 -- r_associated #0: 30 / 0.405 -> en:contraindications aspect
    n1=caspase 14 | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=30
  33. caspase 14 -- r_associated #0: 23 / 0.311 -> en:caspase 14
    n1=caspase 14 | n2=en:caspase 14 | rel=r_associated | relid=0 | w=23
  34. caspase 14 -- r_associated #0: 10 / 0.135 -> effet d'un médicament
    n1=caspase 14 | n2=effet d'un médicament | rel=r_associated | relid=0 | w=10
  35. caspase 14 -- r_associated #0: 9 / 0.122 -> caspase
    n1=caspase 14 | n2=caspase | rel=r_associated | relid=0 | w=9
  36. caspase 14 -- r_associated #0: 1 / 0.014 -> en:amino acid, peptide, or protein
    n1=caspase 14 | n2=en:amino acid, peptide, or protein | rel=r_associated | relid=0 | w=1
≈ 34 relations entrantes

  1. en:caspase 14 --- r_associated #0: 26 --> caspase 14
    n1=en:caspase 14 | n2=caspase 14 | rel=r_associated | relid=0 | w=26
  2. chimie --- r_associated #0: 22 --> caspase 14
    n1=chimie | n2=caspase 14 | rel=r_associated | relid=0 | w=22
  3. en:analysis aspect --- r_associated #0: 20 --> caspase 14
    n1=en:analysis aspect | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  4. en:aspects of adverse effects --- r_associated #0: 20 --> caspase 14
    n1=en:aspects of adverse effects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  5. en:aspects of radiation effects --- r_associated #0: 20 --> caspase 14
    n1=en:aspects of radiation effects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  6. en:bioformation --- r_associated #0: 20 --> caspase 14
    n1=en:bioformation | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  7. en:caspase-3 --- r_associated #0: 20 --> caspase 14
    n1=en:caspase-3 | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  8. en:caspase-6 --- r_associated #0: 20 --> caspase 14
    n1=en:caspase-6 | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  9. en:caspase-7 --- r_associated #0: 20 --> caspase 14
    n1=en:caspase-7 | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  10. en:caspases, effector --- r_associated #0: 20 --> caspase 14
    n1=en:caspases, effector | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  11. en:cellular secretion --- r_associated #0: 20 --> caspase 14
    n1=en:cellular secretion | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  12. en:chemical aspects --- r_associated #0: 20 --> caspase 14
    n1=en:chemical aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  13. en:chemical synthesis --- r_associated #0: 20 --> caspase 14
    n1=en:chemical synthesis | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  14. en:contraindications aspect --- r_associated #0: 20 --> caspase 14
    n1=en:contraindications aspect | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  15. en:deficiency aspects --- r_associated #0: 20 --> caspase 14
    n1=en:deficiency aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  16. en:drug effect --- r_associated #0: 20 --> caspase 14
    n1=en:drug effect | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  17. en:exposure as collected domain --- r_associated #0: 20 --> caspase 14
    n1=en:exposure as collected domain | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  18. en:genetic aspects --- r_associated #0: 20 --> caspase 14
    n1=en:genetic aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  19. en:historical aspects qualifier --- r_associated #0: 20 --> caspase 14
    n1=en:historical aspects qualifier | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  20. en:immunology aspects --- r_associated #0: 20 --> caspase 14
    n1=en:immunology aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  21. en:in blood --- r_associated #0: 20 --> caspase 14
    n1=en:in blood | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  22. en:in cerebrospinal fluid --- r_associated #0: 20 --> caspase 14
    n1=en:in cerebrospinal fluid | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  23. en:in urine --- r_associated #0: 20 --> caspase 14
    n1=en:in urine | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  24. en:mechanism of action qualifier --- r_associated #0: 20 --> caspase 14
    n1=en:mechanism of action qualifier | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  25. en:metabolic aspects --- r_associated #0: 20 --> caspase 14
    n1=en:metabolic aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  26. en:pharmacokinetic aspects --- r_associated #0: 20 --> caspase 14
    n1=en:pharmacokinetic aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  27. en:physiological aspects --- r_associated #0: 20 --> caspase 14
    n1=en:physiological aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  28. en:poisoning aspects --- r_associated #0: 20 --> caspase 14
    n1=en:poisoning aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  29. en:standards characteristics --- r_associated #0: 20 --> caspase 14
    n1=en:standards characteristics | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  30. en:taxonomic --- r_associated #0: 20 --> caspase 14
    n1=en:taxonomic | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  31. en:therapeutic use - qualifier --- r_associated #0: 20 --> caspase 14
    n1=en:therapeutic use - qualifier | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  32. en:toxicity aspects --- r_associated #0: 20 --> caspase 14
    n1=en:toxicity aspects | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  33. en:ultrastructure --- r_associated #0: 20 --> caspase 14
    n1=en:ultrastructure | n2=caspase 14 | rel=r_associated | relid=0 | w=20
  34. taxinomique --- r_associated #0: 10 --> caspase 14
    n1=taxinomique | n2=caspase 14 | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr